Skip to main content

AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise.  The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).

Learn more about the comment process

AMIA responses are arranged by Federal Agency and Congressional Committee.

Showing 41 - 50 out of 57

AMIA Submits Comments to HHS on the Common Rule

October 25, 2011

This week AMIA submitted comments to the Department of Health and Human Services (HHS) in response to the a request for comments regarding Human Subject Research Protections: Enhancing Protections for Research Subjects and Reducing Burden, Delay, and Ambiguity for Investigators (aka "the Common Rule").

Click below to read AMIA's comments.

AMIA Comments on FDA Mobile Medical Apps Draft Guidance

October 19, 2011

AMIA recently issued comments in response to a U.S. Food and Drug Administration (FDA) draft guidance on mobile medical applications. In the comments, AMIA president Ted Shortliffe noted, among other things, the need for additional clarification, definitions, terms, and terminology in the guidance. Click below to read AMIA's full comments.

AMIA Comments on NINR Draft Strategic Plan 2011

March 17, 2011

AMIA submitted comments recently to the National Institute of Nursing Research (NINR) in response to their request for public comments on the latest draft of the Institute's strategic plan. The association's comments were informed by AMIA's Nursing Informatics Working Group (NIWG), which promotes the advancement of nursing informatics within the […]

AMIA Testifies before ONC's Privacy & Security Tiger Team

December 9, 2010

AMIA’s testimony examines patient data matching before ONC’s Privacy & Security Tiger Team. AMIA's Brad Malin discusses some concerns of the accuracy in patient matching and the implications of misidentified data in patient care and biomedical research, which could lead to false match or false non-match.

AMIA Comments on HIPAA Enforcement Interim Rule

December 24, 2009

AMIA comments on the interim final rule, which amends the enforcement regulations promulgated under the Health Insurance Portability and Accountability Act of 1996 (HIPAA) to conform to the revisions made pursuant to the Health Information Technology for Economic and Clinical Health Act (HITECH) for which the Secretary may impose a […]

AMIA Comments on Genetic Information Nondiscrimination Act of 2008 (GINA)

December 4, 2009

AMIA comments on the proposed rule to the Genetic Information Nondiscrimination Act of 2008 (GINA). AMIA supports the inclusion in the HIPAA Privacy Rule to prohibit against the use of genetic information for underwriting purposes. Covered entities (CE) would use genetic information only to benefit the individual and not for […]

AMIA Comments on Breach Notification

October 22, 2009

AMIA comments on the Breach Notification for Unsecured Protected Health Information Interim final rule. AMIA supports ARRA’s definition of breach but offers suggestions for amendment. The comment also discusses the kinds of triggers the notification obligation CEs have to determine in order to report to individuals of compromised PHI.